{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:42:13Z","timestamp":1792575733147,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05735-3","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:41:31Z","timestamp":1789119691000},"page":"5419-5435","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mitochondria-mediated anticancer effects of two previously characterized COX-2 inhibitors in hepatocellular carcinoma"],"prefix":"10.1007","volume":"481","author":[{"given":"Roya","family":"Mirzaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa Manafi","family":"Varkiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Moosavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Habibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshteh","family":"Niknam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa Azami","family":"Movahed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Zarghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalal","family":"Pourahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"5735_CR1","first-page":"1387","volume":"33","author":"T Morisaki","year":"2013","unstructured":"Morisaki T, Umebayashi M, Kiyota A et al (2013) Combining celecoxib with sorafenib synergistically inhibits hepatocellular carcinoma cells in vitro. Anticancer Res 33:1387\u20131395","journal-title":"Anticancer Res"},{"key":"5735_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s43066-023-00306-3","volume":"14","author":"TA Addissouky","year":"2024","unstructured":"Addissouky TA, Sayed IETE, Ali MM et al (2024) Latest advances in hepatocellular carcinoma management and prevention through advanced technologies. Egypt Liver J 14:2","journal-title":"Egypt Liver J"},{"key":"5735_CR3","doi-asserted-by":"publisher","first-page":"6437","DOI":"10.7150\/jca.47532","volume":"11","author":"J-W Hu","year":"2020","unstructured":"Hu J-W, Chen B, Zhang J et al (2020) Novel combination of celecoxib and metformin improves the antitumor effect by inhibiting the growth of Hepatocellular Carcinoma. J Cancer 11:6437","journal-title":"J Cancer"},{"key":"5735_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.637504","volume":"11","author":"D Pu","year":"2021","unstructured":"Pu D, Yin L, Huang L et al (2021) Cyclooxygenase-2 inhibitor: a potential combination strategy with immunotherapy in cancer. Front Oncol 11:637504","journal-title":"Front Oncol"},{"key":"5735_CR5","doi-asserted-by":"publisher","first-page":"504","DOI":"10.2174\/0118715206269563231220104846","volume":"24","author":"N Ahmadi","year":"2024","unstructured":"Ahmadi N, Khoramjouy M, Azami Movahed M et al (2024) Design, synthesis, in vitro and in vivo evaluation of new imidazo [1, 2-a] pyridine derivatives as cyclooxygenase-2 inhibitors. Anti-Cancer Agents Med Chem 24:504\u2013513","journal-title":"Anti-Cancer Agents Med Chem"},{"key":"5735_CR6","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ejmech.2018.09.005","volume":"158","author":"UM Ammar","year":"2018","unstructured":"Ammar UM, Abdel-Maksoud MS, Oh C-H (2018) Recent advances of RAF (rapidly accelerated fibrosarcoma) inhibitors as anti-cancer agents. Eur J Med Chem 158:144\u2013166","journal-title":"Eur J Med Chem"},{"key":"5735_CR7","doi-asserted-by":"publisher","first-page":"36439","DOI":"10.1039\/D3RA07842F","volume":"13","author":"R Krishnamoorthy","year":"2023","unstructured":"Krishnamoorthy R, Anaikutti P (2023) Iodine catalyzed synthesis of imidazo [1, 2-a] pyrazine and imidazo [1, 2-a] pyridine derivatives and their anticancer activity. RSC Adv 13:36439\u201336454","journal-title":"RSC Adv"},{"key":"5735_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13065-025-01412-6","volume":"19","author":"I Al-Qadi","year":"2025","unstructured":"Al-Qadi I, Hanania M, Warad I et al (2025) Synthesis and biological activities of 3-aminoimidazo [1, 2-\u03b1] pyridine compounds. BMC Chem 19:48","journal-title":"BMC Chem"},{"key":"5735_CR9","first-page":"7951","volume":"2","author":"S Chtita","year":"2013","unstructured":"Chtita S, Ghamali M, Larif M et al (2013) Prediction of biological activity of imidazo [1, 2-a] pyrazine derivatives by combining DFT and QSAR results. Int J Innovative Res Sci Eng Technol 2:7951\u20137962","journal-title":"Int J Innovative Res Sci Eng Technol"},{"key":"5735_CR10","doi-asserted-by":"publisher","first-page":"15287","DOI":"10.3390\/molecules200815287","volume":"20","author":"MG Badrey","year":"2015","unstructured":"Badrey MG, Abdel-Aziz HM, Gomha SM et al (2015) Design and synthesis of imidazopyrazolopyridines as novel selective COX-2 inhibitors. Molecules 20:15287\u201315303","journal-title":"Molecules"},{"key":"5735_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.363","volume":"4","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Liu Y, Sun J et al (2023) Arachidonic acid metabolism in health and disease. MedComm 4:e363","journal-title":"MedComm"},{"key":"5735_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7838583","volume":"2022","author":"H Fahmideh","year":"2022","unstructured":"Fahmideh H, Shapourian H, Moltafeti R et al (2022) The role of natural products as inhibitors of JAK\/STAT signaling pathways in glioblastoma treatment. Oxid Med Cell Longev 2022:7838583. https:\/\/doi.org\/10.1155\/2022\/7838583","journal-title":"Oxid Med Cell Longev"},{"key":"5735_CR13","unstructured":"Bhat IA, Bhat AM, Abdullah ST (2025) Apoptosis-Mechanisms, Regulation in Pathology, and Therapeutic. Cell death Regul Pathol : 97"},{"key":"5735_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/bmri\/4464604","volume":"2026","author":"M Azimi","year":"2026","unstructured":"Azimi M, Eghdami A, Keyvani B et al (2026) Induction of apoptosis in colorectal cancer cells by zinc oxide nanoparticles extracted from Lactiplantibacillus plantarum with gene expression control of apoptosis-related genes. BioMed Res Int 2026:4464604","journal-title":"BioMed Res Int"},{"key":"5735_CR15","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1039\/D5MD00196J","volume":"16","author":"AE Kassab","year":"2025","unstructured":"Kassab AE (2025) Recent advances in targeting COX-2 for cancer therapy: a review. RSC Med Chem 16:2974\u20133002","journal-title":"RSC Med Chem"},{"key":"5735_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fj.02-0947fje","volume":"17","author":"V Jendrossek","year":"2003","unstructured":"Jendrossek V, Handrick R, Belka C (2003) Celecoxib activates a novel mitochondrial apoptosis signaling pathway. FASEB J 17:1\u201325. https:\/\/doi.org\/10.1096\/fj.02-0947fje","journal-title":"FASEB J"},{"key":"5735_CR17","doi-asserted-by":"publisher","DOI":"10.2174\/0113852728367154250617095504","author":"S Patel","year":"2025","unstructured":"Patel S, Yaduwanshi PS, Jain A et al (2025) Exploring synthesis and functionalization of imidazo [1, 2\u02d7 a] pyridines: a promising heterocyclic framework. Curr Org Chem. https:\/\/doi.org\/10.2174\/0113852728367154250617095504","journal-title":"Curr Org Chem"},{"key":"5735_CR18","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1007\/s00044-023-03041-x","volume":"32","author":"MA Movahed","year":"2023","unstructured":"Movahed MA, Abbasi FK, Rajabi M et al (2023) Design, synthesis, and biological evaluation of new 2-(4-(methylsulfonyl) phenyl)-N-phenylimidazo [1, 2-a] pyridin-3-amine as selective COX-2 inhibitors. Med Chem Res 32:856\u2013868","journal-title":"Med Chem Res"},{"key":"5735_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.201800265","volume":"352","author":"M Azami Movahed","year":"2019","unstructured":"Azami Movahed M, Daraei B, Shahosseini S et al (2019) Design, synthesis, and biological evaluation of new pyrazino[1,2-a]benzimidazole derivatives as selective cyclooxygenase (COX-2) inhibitors. Arch Pharm (Weinheim) 352:1800265. https:\/\/doi.org\/10.1002\/ardp.201800265","journal-title":"Arch Pharm (Weinheim)"},{"key":"5735_CR20","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1080\/02772248.2015.1047671","volume":"97","author":"E Seydi","year":"2015","unstructured":"Seydi E, Rajabi M, Salimi A et al (2015) Involvement of mitochondrial-mediated caspase-3 activation and lysosomal labilization in acrylamide-induced liver toxicity. Toxicol Environ Chem 97:563\u2013575","journal-title":"Toxicol Environ Chem"},{"key":"5735_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55\u201363","journal-title":"J Immunol Methods"},{"key":"5735_CR22","unstructured":"Aksu M (2022) Colorimetric Cytotoxicity Assays. IntechOpen eBooks"},{"key":"5735_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0022-1759(95)00072-I","volume":"184","author":"I Vermes","year":"1995","unstructured":"Vermes I, Haanen C, Steffens-Nakken H et al (1995) A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods 184:39\u201351","journal-title":"J Immunol Methods"},{"key":"5735_CR24","doi-asserted-by":"publisher","first-page":"31641","DOI":"10.1039\/D3RA05809C","volume":"13","author":"C Moldovan","year":"2023","unstructured":"Moldovan C, Onaciu A, Toma V et al (2023) Current trends in luminescence-based assessment of apoptosis. RSC Adv 13:31641\u201331658","journal-title":"RSC Adv"},{"key":"5735_CR25","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.33073","volume":"15","author":"E Seydi","year":"2015","unstructured":"Seydi E, Motallebi A, Dastbaz M et al (2015) Selective toxicity of Persian Gulf sea cucumber (Holothuria parva) and sponge (Haliclona oculata) methanolic extracts on liver mitochondria isolated from an animal model of hepatocellular carcinoma. Hepat Mon 15:e33073","journal-title":"Hepat Mon"},{"key":"5735_CR26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1196\/annals.1378.010","volume":"1090","author":"M Ghazi-Khansari","year":"2006","unstructured":"Ghazi-Khansari M, Mohammadi\u2010Bardbori A, Hosseini MJ (2006) Using Janus green B to study paraquat toxicity in rat liver mitochondria: role of ACE inhibitors (thiol and nonthiol ACEi). Ann N Y Acad Sci 1090:98\u2013107","journal-title":"Ann N Y Acad Sci"},{"key":"5735_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0005-2728(03)00110-5","volume":"1606","author":"A Baracca","year":"2003","unstructured":"Baracca A, Sgarbi G, Solaini G et al (2003) Rhodamine 123 as a probe of mitochondrial membrane potential: evaluation of proton flux through F0 during ATP synthesis. Biochim et Biophys Acta (BBA)-Bioenergetics 1606:137\u2013146","journal-title":"Biochim et Biophys Acta (BBA)-Bioenergetics"},{"key":"5735_CR28","first-page":"93","volume":"13","author":"M Faizi","year":"2014","unstructured":"Faizi M, Salimi A, Rasoulzadeh M et al (2014) Schizophrenia induces oxidative stress and cytochrome C release in isolated rat brain mitochondria: a possible pathway for induction of apoptosis and neurodegeneration. Iran J Pharm Res: IJPR 13:93","journal-title":"Iran J Pharm Res: IJPR"},{"key":"5735_CR29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3109\/00498254.2015.1046975","volume":"46","author":"A Salimi","year":"2016","unstructured":"Salimi A, Eybagi S, Seydi E et al (2016) Toxicity of macrolide antibiotics on isolated heart mitochondria: a justification for their cardiotoxic adverse effect. Xenobiotica 46:82\u201393","journal-title":"Xenobiotica"},{"key":"5735_CR30","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1097\/HEP.0000000000000237","volume":"79","author":"AD Ladd","year":"2024","unstructured":"Ladd AD, Duarte S, Sahin I et al (2024) Mechanisms of drug resistance in HCC. Hepatology 79:926\u2013940","journal-title":"Hepatology"},{"key":"5735_CR31","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12935-018-0538-7","volume":"18","author":"K Lohitesh","year":"2018","unstructured":"Lohitesh K, Chowdhury R, Mukherjee S (2018) Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight. Cancer Cell Int 18:44","journal-title":"Cancer Cell Int"},{"key":"5735_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202300252","volume":"18","author":"A Spallarossa","year":"2023","unstructured":"Spallarossa A, Rapetti F, Signorello MG et al (2023) Insights into the pharmacological activity of the imidazo\u2212 pyrazole scaffold. ChemMedChem 18:e202300252","journal-title":"ChemMedChem"},{"key":"5735_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28217440","volume":"28","author":"G-Q Chen","year":"2023","unstructured":"Chen G-Q, Guo H-Y, Quan Z-S et al (2023) Natural products\u2013pyrazine hybrids: a review of developments in medicinal chemistry. Molecules 28:7440","journal-title":"Molecules"},{"key":"5735_CR34","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.cell.2016.07.002","volume":"166","author":"S Vyas","year":"2016","unstructured":"Vyas S, Zaganjor E, Haigis MC (2016) Mitochondria and cancer. Cell 166:555\u2013566","journal-title":"Cell"},{"key":"5735_CR35","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.3390\/cells10081901","volume":"10","author":"H-Y Lee","year":"2021","unstructured":"Lee H-Y, Nga HT, Tian J et al (2021) Mitochondrial metabolic signatures in hepatocellular carcinoma. Cells 10:1901","journal-title":"Cells"},{"key":"5735_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9111664","volume":"9","author":"M Marsico","year":"2021","unstructured":"Marsico M, Santarsiero A, Pappalardo I et al (2021) Mitochondria-mediated apoptosis of HCC cells triggered by knockdown of glutamate dehydrogenase 1: perspective for its inhibition through quercetin and permethylated anigopreissin A. Biomedicines 9:1664","journal-title":"Biomedicines"},{"key":"5735_CR37","doi-asserted-by":"crossref","unstructured":"Chakraborty S, Choudhuri A, Mishra A et al (2024) S-(de)-Nitrosylation of Caspases: The Achilles Heel in the Expanding Sea of Cancer Treatment Regimens. Springer","DOI":"10.1007\/16833_2024_296"},{"key":"5735_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.713721","volume":"11","author":"J Bian","year":"2021","unstructured":"Bian J, Zhang D, Wang Y et al (2021) Mitochondrial quality control in hepatocellular carcinoma. Front Oncol 11:713721","journal-title":"Front Oncol"},{"key":"5735_CR39","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.3892\/mmr.2014.2461","volume":"10","author":"D Shao","year":"2014","unstructured":"Shao D, Kan M, Qiao P et al (2014) Celecoxib induces apoptosis via a mitochondria-dependent pathway in the H22 mouse hepatoma cell line. Mol Med Rep 10:2093\u20132098","journal-title":"Mol Med Rep"},{"key":"5735_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092864","volume":"9","author":"X Dong","year":"2014","unstructured":"Dong X, Li R, Xiu P et al (2014) Meloxicam executes its antitumor effects against hepatocellular carcinoma in COX-2-dependent and-independent pathways. PLoS One 9:e92864","journal-title":"PLoS One"},{"key":"5735_CR41","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1038\/onc.2017.73","volume":"36","author":"H Chen","year":"2017","unstructured":"Chen H, Cai W, Chu E et al (2017) Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice. Oncogene 36:4415\u20134426","journal-title":"Oncogene"},{"key":"5735_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.834859","volume":"10","author":"C Chen","year":"2022","unstructured":"Chen C, Guan J, Gu X et al (2022) Prostaglandin E2 and receptors: insight into tumorigenesis, tumor progression, and treatment of hepatocellular carcinoma. Front Cell Dev Biol 10:834859","journal-title":"Front Cell Dev Biol"},{"key":"5735_CR43","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1158\/1078-0432.CCR-17-2725","volume":"24","author":"X-F Dong","year":"2018","unstructured":"Dong X-F, Liu T-Q, Zhi X-T et al (2018) COX-2\/PGE2 axis regulates HIF2\u03b1 activity to promote hepatocellular carcinoma hypoxic response and reduce the sensitivity of sorafenib treatment. Clin Cancer Res 24:3204\u20133216","journal-title":"Clin Cancer Res"},{"key":"5735_CR44","doi-asserted-by":"publisher","first-page":"7059","DOI":"10.1158\/0008-5472.CAN-06-0325","volume":"66","author":"MA Kern","year":"2006","unstructured":"Kern MA, Haugg AM, Koch AF et al (2006) Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma. Cancer Res 66:7059\u20137066","journal-title":"Cancer Res"},{"key":"5735_CR45","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00044-023-03022-0","volume":"32","author":"M Bayanati","year":"2023","unstructured":"Bayanati M, Khoramjouy M, Faizi M et al (2023) Novel Benzo [4, 5] imidazo [1, 2-a] pyrimidine derivatives as selective Cyclooxygenase-2 inhibitors: design, synthesis, docking studies, and biological evaluation. Med Chem Res 32:495\u2013505","journal-title":"Med Chem Res"},{"key":"5735_CR46","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s00204-013-1034-4","volume":"87","author":"K Sinha","year":"2013","unstructured":"Sinha K, Das J, Pal PB et al (2013) Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis. Arch Toxicol 87:1157\u20131180","journal-title":"Arch Toxicol"},{"key":"5735_CR47","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12929-022-00859-2","volume":"29","author":"C-L Kuo","year":"2022","unstructured":"Kuo C-L, Ponneri Babuharisankar A, Lin Y-C et al (2022) Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend? J Biomed Sci 29:74","journal-title":"J Biomed Sci"},{"key":"5735_CR48","first-page":"1288","volume":"17","author":"M Shahrasbi","year":"2018","unstructured":"Shahrasbi M, Movahed MA, Dadras OG et al (2018) Design, synthesis and biological evaluation of new Imidazo [2, 1-B] thiazole derivatives as selective COX-2 inhibitors. Iran J Pharm Res: IJPR 17:1288","journal-title":"Iran J Pharm Res: IJPR"},{"key":"5735_CR49","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s12672-025-02773-z","volume":"16","author":"S Sadrinasab","year":"2025","unstructured":"Sadrinasab S, Saket S, Pourmohammadi N et al (2025) Modern therapeutic approaches for hepatic tumors: progress, limitations, and future directions. Discover Oncol 16:959","journal-title":"Discover Oncol"},{"key":"5735_CR50","doi-asserted-by":"publisher","first-page":"25","DOI":"10.20892\/j.issn.2095-3941.2022.0449","volume":"20","author":"C Yao","year":"2023","unstructured":"Yao C, Wu S, Kong J et al (2023) Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies. Cancer Biol Med 20:25\u201343","journal-title":"Cancer Biol Med"},{"key":"5735_CR51","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","volume":"5","author":"W Tang","year":"2020","unstructured":"Tang W, Chen Z, Zhang W et al (2020) The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects. Signal Transduct Target therapy 5:87","journal-title":"Signal Transduct Target therapy"},{"key":"5735_CR52","doi-asserted-by":"publisher","first-page":"5489","DOI":"10.3390\/curroncol29080434","volume":"29","author":"MY Feng","year":"2022","unstructured":"Feng MY, Chan LL, Chan SL (2022) Drug treatment for advanced hepatocellular carcinoma: first-line and beyond. Curr Oncol 29:5489\u20135507","journal-title":"Curr Oncol"},{"key":"5735_CR53","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1158\/1078-0432.CCR-16-3171","volume":"23","author":"AG Duffy","year":"2017","unstructured":"Duffy AG, Ma C, Ulahannan SV et al (2017) Phase I and preliminary phase II study of TRC105 in combination with sorafenib in hepatocellular carcinoma. Clin Cancer Res 23:4633\u20134641","journal-title":"Clin Cancer Res"},{"key":"5735_CR54","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1177\/2050640615583587","volume":"3","author":"A Duffy","year":"2015","unstructured":"Duffy A, Ulahannan S, Cao L et al (2015) A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib. United Eur Gastroenterol J 3:453\u2013461","journal-title":"United Eur Gastroenterol J"},{"key":"5735_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/su15021195","volume":"15","author":"AG Mukherjee","year":"2023","unstructured":"Mukherjee AG, Renu K, Gopalakrishnan AV et al (2023) Heavy metal and metalloid contamination in food and emerging technologies for its detection. Sustainability 15:1195","journal-title":"Sustainability"},{"key":"5735_CR56","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1002\/jcp.25664","volume":"232","author":"M Ravi","year":"2017","unstructured":"Ravi M, Ramesh A, Pattabhi A (2017) Contributions of 3D cell cultures for cancer research. J Cell Physiol 232:2679\u20132697","journal-title":"J Cell Physiol"},{"key":"5735_CR57","first-page":"365","volume-title":"Seminars in cancer biology","author":"JB Kim","year":"2005","unstructured":"Kim JB (2005) Three-dimensional tissue culture models in cancer biology. Seminars in cancer biology. Elsevier, pp 365\u2013377"},{"key":"5735_CR58","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/biot.201300492","volume":"9","author":"JA Hickman","year":"2014","unstructured":"Hickman JA, Graeser R, de Hoogt R et al (2014) Three-dimensional models of cancer for pharmacology and cancer cell biology: capturing tumor complexity in vitro\/ex vivo. Biotechnol J 9:1115\u20131128","journal-title":"Biotechnol J"},{"key":"5735_CR59","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/jnci\/djj206","volume":"98","author":"S Gr\u00f6sch","year":"2006","unstructured":"Gr\u00f6sch S, Maier TJ, Schiffmann S et al (2006) Cyclooxygenase-2 (COX-2)\u2013independent anticarcinogenic effects of selective COX-2 inhibitors. J Natl Cancer Inst 98:736\u2013747","journal-title":"J Natl Cancer Inst"},{"key":"5735_CR60","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-023-02256-7","volume":"41","author":"P Rodrigues","year":"2024","unstructured":"Rodrigues P, Bangali H, Hammoud A et al (2024) COX 2-inhibitors; a thorough and updated survey into combinational therapies in cancers. Med Oncol 41:41","journal-title":"Med Oncol"},{"key":"5735_CR61","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3390\/ph15070827","volume":"15","author":"AA El-Malah","year":"2022","unstructured":"El-Malah AA, Gineinah MM, Deb PK et al (2022) Selective COX-2 inhibitors: road from success to controversy and the quest for repurposing. Pharmaceuticals 15:827","journal-title":"Pharmaceuticals"},{"key":"5735_CR62","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.freeradbiomed.2024.04.219","volume":"219","author":"C Forenzo","year":"2024","unstructured":"Forenzo C, Larsen J (2024) Bridging clinical radiotherapy and space radiation therapeutics through reactive oxygen species (ROS)-triggered delivery. Free Radic Biol Med 219:88\u2013103","journal-title":"Free Radic Biol Med"},{"key":"5735_CR63","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12964-025-02227-7","volume":"23","author":"M Kang","year":"2025","unstructured":"Kang M, Devarasou S, Sung NJ et al (2025) EMT induction in normal breast epithelial cells by COX2-expressing fibroblasts. Cell Commn Signal 23:237","journal-title":"Cell Commn Signal"},{"key":"5735_CR64","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41419-024-06939-5","volume":"15","author":"X An","year":"2024","unstructured":"An X, Yu W, Liu J et al (2024) Oxidative cell death in cancer: mechanisms and therapeutic opportunities. Cell Death Dis 15:556","journal-title":"Cell Death Dis"},{"key":"5735_CR65","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3390\/cells10030537","volume":"10","author":"A Picca","year":"2021","unstructured":"Picca A, Calvani R, Coelho-Junior HJ et al (2021) Cell death and inflammation: the role of mitochondria in health and disease. Cells 10:537","journal-title":"Cells"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05735-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05735-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05735-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:02:47Z","timestamp":1792573367000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05735-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":65,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["5735"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05735-3","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"9 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}